Open access peer-reviewed chapter

Spontaneous Prematurity, Innate Immune System, and Oxidative Stress at the Maternal-Fetal Interface: An Overview

Written By

Natália Prearo Moço, Bruna Ribeiro de Andrade Ramos, Mariana de Castro Silva, Jossimara Polettini, Ramkumar Menon and Márcia Guimarães da Silva

Submitted: January 10th, 2019 Reviewed: July 3rd, 2019 Published: November 25th, 2019

DOI: 10.5772/intechopen.88379

Chapter metrics overview

712 Chapter Downloads

View Full Metrics


Despite the multifactorial etiology of prematurity, intra-amniotic infection is present in 25–40% of preterm pregnancies. Bacteria in amniotic cavity synthesize phospholipases associated with the production of prostaglandins that leads to rupture of fetal membranes and uterine contractions. Bacterial pathogen-associated molecular patterns (PAMPs) activate pattern recognition receptors (PRRs) such as Toll-like (TLRs) and NOD-like receptors (NLRs), triggering pathways that culminate in the production of cytokines that further increase prostaglandin release. Importantly, endogenous molecules called damage-associated molecular patterns (DAMPs) released under stressful conditions can also activate PRRs. Risk factors for both preterm labor (PTL) and preterm premature rupture of membranes (PPROM), including infection-induced inflammation, may cause an increase of ROS release and depletion of antioxidant defenses. In spite of the similarity between the pathophysiology of PTL and PPROM, there are significant differences regarding molecular mediators, degree of tissue damage, and oxidative stress present in these two conditions. PPROM seems to be a consequence of notable tissue damage resulting from chronic oxidative stress, while PTL is associated with minimal tissue degradation resulting from acute exposure and greater antioxidant status. A better understanding of prematurity pathophysiology and the differences between PTL and PPROM can benefit therapeutic approaches to prevent these important inflammatory syndromes.


  • prematurity
  • innate immune system
  • oxidative stress

1. Introduction

Innate immune responses play a critical role at different stages of gestation, and a successful pregnancy depends on the balance between anti- and pro-inflammatory molecules. In addition, normal pregnancy is marked by increased oxidative stress, due to increased fetal metabolism, decreased maternal antioxidant reserves, or maternal supply of substrate. Disruption of these two major mechanisms, inflammation and oxidative stress, is closely linked to spontaneous prematurity.


2. Innate immunity and pattern recognition receptors (PRRs)

Innate immunity is a primordial defense system implicated in the identification and eradication of infectious agents that also recognizes products from damaged cells and works to eliminate them. The innate immune system acts through the recognition of molecular structures common to microorganisms, called pathogen-associated molecular patterns (PAMPs) and endogenous molecules called damage-associated molecular patterns (DAMPs) [1], which are passively released from damaged and dying cells, or actively secreted by immune cells or severely stressed cells [2].

PAMPs and DAMPs are recognized by pattern recognition receptors (PRRs) expressed by several cell types [1, 3]. Their ubiquitous localization in cells enables PRRs to recognize microorganisms present in distinct compartments. Membrane-bound PRRs are located in the plasma membrane, endosomal and lysosomal membranes, while cytosolic PRRs are located in the cytoplasm of cells [1, 3].

Toll-like receptors (TLR) are PRRs coupled to the cell membrane [4], composed of type I integral membrane glycoproteins, comprised of an ectodomain with a leucine-rich repeat domain (LRR), an endodomain with Toll/IL-1 receptor (TIR), that shares a 200-amino acid conserved region with interleukin-1 (IL-1) and IL-18 receptors, and a short transmembrane domain [1, 5]. The ectodomain recognizes specific PAMPs, while the endodomain recruits adaptor molecules, enabling the intracellular cascade [5].

The first group of TLRs is responsible for the recognition of structural components of microorganisms and comprises receptors expressed on the cell surface, including TLR-1, TLR-2, TLR-4, TLR-5, TLR-6, and TLR-11 [4]. The second group includes receptors exclusively expressed in intracellular vesicles, TLR-3, TLR-7, and TLR-9, which recognize nucleic acids from microorganisms [4, 6].

PAMPs’ recognition by TLRs activates intracellular pathways that lead to the activation of transcription factors responsible for the expression of genes involved in inflammatory and antiviral responses [1, 5, 6]. Among the transcription factors activated by TLR signaling, the most common factors are nuclear factor kappa-B (NF-κB), activating protein 1 (AP-1), interferon regulatory factor 3 (IRF3), and IRF7 [1]. Activation of NF-κB and AP-1 results in the transcription of several genes of pro-inflammatory effector molecules, such as cytokines and chemokines, while the activation of IRF3 and IRF7 leads to the production of type I interferons that are involved in antiviral immunity [1, 3].

Intracellular signaling through NF-κB and AP-1 is very well characterized [47], and TLR-4 and TLR-9 are shown as examples of TLRs on the cell surface and in endosomes, respectively, in Figure 1. The activation of TLRs by PAMPs and DAMPs triggers the formation of a signaling complex, a myddosome, composed of protein MyD88 and interleukin-1 receptor-associated kinase 1 (IRAK1) and IRAK4, leading to activation of pro-inflammatory transcription factors, NF-kB and AP-1.

Figure 1.

Overview of TLR signaling pathways. Activation of TLRs on the cell surface or endosomal membranes and formation of myddosome complex, leading to activation of pro-inflammatory transcription factors NF-kB and AP-1. Communication between TLR and the myddosome occurs through interaction of the TIR domain of the Toll-like receptor with the TIR domain of MyD88 and depends on the adapter molecule called MAL, allowing the myddosome to form a helical structure. IRAK-4 activates IRAK-1, which undergoes autophosphorylation. Phosphorylated IRAK-1 then binds to TRAF-6, resulting in the activation of the TAK-1, which results in activation of the cascade of KKs that phosphorylate the inhibitory protein of NF-kB, leading to activation of NF-kB. Additionally, the activation of TAK-1 protein also results in activation of MAPKs, leading to activation of the transcription factor AP-1. AP-1, activator protein 1; IKK, IκB kinase; IRAK, interleukin-1 receptor-associated kinase; MAL, MyD88-adapter-like protein; MAPK, mitogen-activated protein kinase; MYD88, myeloid differentiation primary response protein 88; TAB, TAK1-binding protein; TAK1, transforming growth factor β (TGF-β)-activated kinase 1; TRAF6, tumor necrosis factor receptor-associated factor 6. Adapted from Kawasaki and Kawai [4].

Although infection is the main stimulus for inflammation, it can also be induced in sterile conditions [8]. Therefore, DAMPs are as important to sterile inflammation as PAMPs are to innate response to microorganisms. DAMPs are endogenous factors that in physiologic conditions are protected from cellular receptors. During tissue damage, DAMPs are liberated from cells and are recognized by immune cells [9]. DAMPs can also be actively secreted by immune and severely stressed cells [2]. Evidence shows that PAMPs and DAMPs act in different ways to stimulate innate immunity. Antigen-presenting cells that are unresponsive to lipopolysaccharide (LPS) can be activated by necrotic cells, indicating that TLR-4 activation, regardless of LPS, occurs in response to endogenous ligands [10]. Similarly, TLR-3 recognizes cells that undergo necrosis during acute inflammatory events, independently of the presence of viral PAMPs [11].

Among the cytosolic PRRs, nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) are of great importance [1]. The NLR family is a class of intracellular receptors that lead to intracellular signaling associated to inflammation, after recognition of PAMPs and DAMPs [1]. Members of the NLR family are characterized by at least three domains: the first one is an LRR domain, responsible for the recognition of the ligand; the second is a NACHT domain that allows the formation of oligomers of NLRs; and the third is the effector domain, usually a caspase recruitment domain (CARD), responsible for the recruitment of accessory proteins [12].

The first NLRs described were NOD-1 and NOD-2 [13], which recognize peptides from degradation of peptidoglycan (PG) that occurs during bacterial growth or destruction. Recognition of PGs by NOD-1 and NOD-2 leads to activation of intracellular pathways, which activate the transcription factor NF-κB, and results in the synthesis of several inflammatory cytokines [14, 15].

Members of the NLR family known as NLRP are capable of responding to cytoplasmic PAMPs and DAMPs through the formation of intracellular signaling complexes, termed inflammasomes [1]. Inflammasomes activate proteases from the caspase family during immune regulation in physiologic and pathologic conditions [16]. The typical structure of the inflammasome consists of NLRP, adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC; also known as PYCARD), and pro-caspase [17]. This transient oligomer starts a cascade that culminates with activation of caspase-1 and production of the active form of IL-1β [18] and IL-18 [19].

The inflammasome NLRP3 is activated in response to several PAMPs, such as flagellin, muramyl dipeptide, LPS, and pore-formation toxins [1]. Moreover, it can be activated by DAMPs, reactive oxygen species (ROS), and environmental signals [16, 20]. Three models describing mechanisms of NRLP3 inflammasome activation have been suggested, which may not be mutually exclusive [21, 22, 23] (Figure 2). In the absence of activation mechanisms, NLRP3 inflammasome complex is autorepressed, owing to an interaction between NATCH domains and LRRs. When one or more activation mechanism is present, this autorepression is removed, resulting in NATCH domain exposure. After this exposure, NLRP3 oligomerizes and recruits ASC and pro-caspase 1, leading to activation of caspase 1 and, consequently, maturation and secretion of IL-1β and IL-18 [21, 22]. The immune response initiated by inflammasome activation shows a close relationship with both physiologic and pathologic processes, as immunological defense and development of inflammatory diseases [20].

Figure 2.

Mechanisms of NLRP3 inflammasome activation. PAMPs and DAMPs are able to induce the activation of the NLRP3 inflammasome by three principal mechanisms: (A) high concentrations of extracellular ATP lead to opening of PANX1 channels by binding to the P2X7 receptor, which results in K+ efflux and influx of PAMPs and DAMPs; (B) phagocytosis of PAMPs and DAMPs leads to disruption of the lysosomal membrane and consequent release of a putative NLRP3-activating molecule, such as cathepsin B; and (C) PAMPs and DAMPs can induce the production of ROS, which may active TXNIP to trigger NLRP3 activation. Activation of the NLRP3 inflammasome results in maturation of caspase-1 and release of mature forms of IL-1 and IL-18. ATP, adenosine triphosphate; DAMPS, damage-associated molecular patterns; LRR, leucine-rich repeat domain; PAMPs, pathogen-associated molecular patterns; PANX1, pannexin-1; ROS, reactive oxygen species; TXNIP, thioredoxin-interacting protein. Adapted from Tschopp and Schroder [23].


3. Pregnancy, maternal immunity, and oxidative stress

During pregnancy, a tightly regulated immune system allows for fetal survival and its adequate development. Among the several modifications made by the maternal immune system to raise tolerance to the allograft fetus, changes in cytokine profiles at the maternal-fetal interface are of great importance [24].

Recent data have shown that a successful pregnancy depends on a complex balance between anti- and pro-inflammatory molecules that changes throughout pregnancy [25, 26]. First trimester is characterized by prevalence of the T helper cell type 1 (Th1) profile. During this stage, an inflammatory microenvironment is necessary for repair and remodeling of the uterine epithelium damaged during implantation and for removal of cellular debris [27]. In the second trimester, there is a prevalence of a Th2 profile [28, 29, 30]. The increased anti-inflammatory activity is important for maintenance of gestation. During the third trimester and labor, the Th1 profile is again predominant systemically [31] in the placental tissue and amniotic fluid, supporting the theory that proinflammatory overload in the intrauterine environment is required for initiation and progression of labor [32, 33]. The final trimester is characterized by an influx of immune cells at the maternal-fetal interface and increased production of pro-inflammatory cytokines [34, 35]. This scenario is essential for the development of the physiologic processes of cervical remodeling, weakening and rupture of fetal membranes, and initiation of uterine contractility, which together culminate in labor [36, 37].

Recent studies have also demonstrated that normal pregnancy is marked by increased oxidative stress, due to increased fetal metabolism, decreased fetal antioxidant reserves, or maternal supply of substrate [38, 39]. Oxidative stress results from exacerbated production of ROS and/or decreased production of antioxidants. Increased oxidative stress has been described in the third trimester of normal pregnancies and labor [38]. During the process of labor, the intensity of uterine contractions increases uterus pressure and can cause interruption or reduction in the uteroplacental blood flow, causing cycles of cellular hypoxia and reoxygenation. These events of parturition are responsible for inducing increased oxidative stress in pregnant women, which must be controlled by their antioxidant system [40, 41].

3.1 Prematurity, inflammatory response, and oxidative stress

Prematurity is the leading cause of neonatal mortality and is also responsible for several short- and long-term morbidities. The risk for these complications is inversely proportional to gestational age at birth [42, 43, 44]. Preterm delivery (PTD) is defined as birth before 37 weeks of gestation, and the incidence of PTD among singleton pregnancies is 9.6% worldwide [45]. Spontaneous PTD can be divided into PTD, which is preceded by preterm labor (PTL) with intact membranes, or by preterm premature rupture of membranes (PPROM) [43, 46]. The incidence of PTL is approximately 60 and 30–40% for PPROM [27, 35, 47].

The etiology of prematurity is multifactorial and includes maternal, paternal, and genetic risks [48, 49, 50, 51, 52], as summarized in Table 1. Despite this multifactorial etiology, studies show that intra-amniotic infections (IAI) are present in 25–40% of preterm pregnancies; however, these frequencies are believed to be underestimated [43, 53].

Sociodemographic characteristics African-American ethnicity
Extreme maternal ages
Low socioeconomic index
Drugs and alcohol abuse
Clinical and gynecological history Previous prematurity
Cervical cone biopsy
Gestational characteristics Multiple gestation pregnancies
Placenta previa
Placenta abruption
Polyhydramnios or oligohydramnios
Uterine and cervical anomalies
Assisted conception
Bacterial vaginosis
 Periodontal infection
 Chlamydial infection
 Intrauterine infection
Paternal High paternal age
Genetics Polymorphisms IL-1R,IL-1β, IL-6, IL-10, MMP-1, MMP-9, TLR-4, TNF-α, HPS47

Table 1.

Risk factors for spontaneous prematurity.

IL-1R, interleukin 1 receptor; IL-1β, interleukin 1 beta; IL-6, interleukin 6; IL-10, interleukin 10; MMP-1, matrix metalloproteinase 1; MMP-9, matrix metalloproteinase 9; TLR-4, Toll-like receptor 4; TNF-α, tumor necrosis factor alpha; HPS47, heat shock protein 47.

The main infection route into the amniotic cavity (AC) is the ascending of bacteria present in the lower genital tract through the endocervical canal. Ascending bacteria can then cross the membranes and invade the AC, with subsequent proliferation in the amniotic fluid. Once microorganisms reach this site, they may travel to the amnion, connective tissue, and even chorion and decidua [54]. The establishment of inflammation in the chorioamniotic membranes in response to bacteria is called chorioamnionitis. Clinical chorioamnionitis (cCAM) occurs in 1–2% of term labors and in 5–10% of PTLs, and this prevalence increases in case of PPROM due to the compromised immune status of the fetal membranes [55]. Histological chorioamnionitis (hCAM) is defined by the presence of polymorphonuclear cells (PMN) in the chorioamniotic membranes. Most cases of hCAM are not followed by clinical signals and symptoms of infection; however, the diagnosis is made in approximately 20% of term pregnancies and over 50% of PTLs [56, 57, 58].

The main microorganisms found in the AC of pregnant women with IAI are Ureaplasma urealitycum, Mycoplasma hominis, and Fusobacterium sp. Gram-negative bacilli such as Bacteroides sp. and Prevotella sp. are also occasionally found, along with Escherichia coli, Gardnerella vaginalis, and group B Streptococcus [59, 60, 61].

The main mechanism by which IAI leads to prematurity is through the production of prostaglandins. Bacteria present in amniotic fluid synthesize phospholipases that, in turn, activate the liberation of arachidonic acid that is metabolized via cyclooxygenase, culminating in the production of prostaglandins. Concomitantly, activation of TLRs and NLRs by PAMPs present in these bacteria initiates production and release of inflammatory cytokines, which increase the release of prostaglandins by macrophage, decidual, and amniotic cells [62, 63].

PTL and PPROM pathways are similar in etiology; however, according to Menon et al. [64], the major difference is the presence of molecular factors associated with infection, such as metalloproteinases and pro-apoptotic factors that are responsible for structural modifications and weakening of fetal membranes in patients undergoing PPROM. These same factors are absent or minimally expressed in PTL. Other differences between PTL and PPROM include the distinct response to microorganisms present in the AC [65, 66, 67] and the intensity of the inflammatory response [68].

Recently, new data have demonstrated the participation of oxidative stress in the physiopathology of PPROM [69, 70], suggesting that this pathology is similar to term pregnancies with regard to degradation, apoptotic signals, oxidative stress, and premature aging of fetal membranes [71, 72]. Increased levels of oxidative stress markers have been not only associated with the third trimester of normal pregnancy and labor [73] but also observed during second trimester pregnancy disorders, such as preeclampsia and low birth weight [74]. Hence, early senescence, a mechanism leading to fetal membrane aging and immunological dysfunction, is a feature of PPROM [72, 75, 76]. Risk factors for both PTL and PPROM, including infection-induced inflammation, may cause an increase of ROS release and depletion of antioxidant defenses [76, 77]. In this way, Menon suggests that PPROM is characterized by pronounced tissue damage resulting from oxidative stress and proteolysis, while PTL has minimal tissue damage [76]. The greater tissue damage present in PPROM may be a consequence of chronic exposure to oxidative stress risk factors. PTL, in turn, may result from acute oxidative stress associated with a better antioxidant status, a scenario in which the capacity of cell resistance is maintained, while the inflammatory response required for initiation of labor pathway is preserved. PPROM also differs from PTL in its molecular signature linked to senescence of fetal membranes, where premature aging and tissue injury cause DAMPs’ release from fetal membranes, which can also contribute to rupture and secondary invasion of microbes due to an immunocompromised environment. Therefore, sterile inflammation by senescent fetal tissues is also a major contributor to PPROM pathology. We have reported differences in antioxidants, telomere length (marker of aging), F2-isoprostanes (markers of oxidative lipid peroxidation), and senescence-associated β-galactosidase (senescence) in fetal membranes and amniotic fluid between PPROM and spontaneous preterm births without PPROM, illustrating the molecular differences between the two phenotypes [75, 78, 79].

3.2 TLRs and NLRs at the maternal-fetal interface and pregnancy complicated by chorioamnionitis and prematurity

Regarding the maternal-fetal interface, expression of TLRs has mainly been investigated in chorioamniotic membranes and the placenta. TLR-2 and TLR-4 are able to recognize most PAMPs present in pathogens involved in AC infections, which are associated with precocious activation of inflammatory response in amniochorionic membranes. Due to this, they are evaluated in most studies concerning TLR expression at maternal-fetal interface.

TLR-2 recognizes microbial lipoproteins, peptidoglycans, and lipoteichoic acid from Gram-positive bacteria, lipoarabinomannan from mycobacteria, zymosan from fungi, and hemagglutinin from smallpox virus [80]. The large capacity of recognition shown by TLR-2 can be explained by its ability to form heterodimers with TLR-1 and TLR-6. The heterodimer TLR-1/TLR-2 recognizes tri-acetylated lipopeptides, while TLR-2/TLR-6 recognizes zymozan and diacetylated lipopeptides [80, 81]. TLR-4 recognizes LPS from Gram-negative bacteria, an important macrophage activator and initiator of septic shock [82].

Kim et al. [83] showed increased expression of TLR-2 in chorioamniotic membranes with hCAM. Our group provided the first report of increase in TLR-1 and TLR-2 mRNAs in fetal membranes of preterm pregnancies with hCAM, when compared to preterm membranes without hCAM [84]. Kumazaki et al. [32] showed that placental macrophages from preterm pregnancies complicated by CAM had increased immunoreactivity to TLR-4, when compared to those without inflammatory infiltrate or term placentas. Using immunohistochemistry techniques, Rindsjö et al. [85] demonstrated an important reduction in TLR-2 expression in placentas in the setting of hCAM and reasoned that the expression of this receptor is probably affected by inflammatory processes in the membranes. Moreover, Kacerovsky et al. [86, 87] showed that pregnant women with PPROM and microbial invasion of the AC had higher levels of soluble TLR-1, TLR-2, TLR-4, and TLR-6 in amniotic fluid.

The expression of TLR-2 and TLR-4 by amniotic epithelium suggests that the epithelium not only works as a mechanical barrier against microorganisms but also plays an important part in the activation of innate immunity [83]. According to Kim et al. [83], the increased expression of these receptors in term membranes reinforces the association between labor and inflammation, as described by Keelan et al. [88]. This upregulation of TLRs may enhance maternal and fetal protection against microbial invasion of the AC. However, Holmlund et al. [89] did not observe differences in TLR-2 and TLR-4 expression between trophoblastic cells, stimulated with zymozan and LPS, and nonstimulated trophoblasts. A possible explanation is that both receptors may be overexpressed in uterine tissue as a defense mechanism, which can protect the fetus against infection during pregnancy and labor. Gonzalez et al. [90] showed that pregnant and nonpregnant mice present different TLR expression in their uterine tissue and that the expression of TLR-2, -3, -4, and -9 increases throughout pregnancy. This finding is in agreement with those of Beijar et al. [91], who reported lower expression of TLR-4 in first trimester villi, when compared to term villi. The apparent disagreement among studies may reflect differences in response to infection in distinct sites of the placenta and gestational tissues.

While several studies showed that gestational tissues express TLRs and are capable of responding to pathogens who present TLR-specific ligands, few studies have discussed the expression of NLRs at the maternal-fetal interface during normal and complicated pregnancies [92, 93, 94, 95, 96, 97]. Gene expression of NOD1 was observed in the placenta of pregnant women at term [92, 93], while first trimester placenta villi expressed NOD1 and NOD2 mRNA, both by syncytiotrophoblast and cytotrophoblast cells [94]. This differential expression is also observed functionally; the first trimester trophoblast cells trigger an inflammatory response following exposure to the NOD1 and NOD2 protein ligands, while trophoblast cells from term pregnancies only respond to the NOD1 ligand [94]. Interestingly, Wang et al. demonstrated that expression of NOD1 and NOD 2 in placental villi and decidua was higher in epithelium than in tissue stroma, reinforcing the idea that epithelial tissues are strongly involved in the host defense response at the maternal-fetal interface [96].

Regarding chorioamnionitis, Romero et al. [95] observed that the expression of NOD2 and NLRP3 in chorioamniotic membranes was higher during labor at term in the presence of histologic chorioamnionitis (hCAM), than in membranes without hCAM; however, only the NLPR3 protein concentration was increased in chorioamniotic membranes in the presence of hCAM. Additionally, Pontillo et al. [97] observed that LPS from Gram-negative bacteria increases expression of the NLRP3 inflammasome in trophoblast and decidual stromal cells, suggesting that this multiprotein complex could be important in placental immune defense against invading pathogens.


4. Conclusion

Inflammation and oxidative stress are important to the success of normal pregnancy, and their disruption is closely related with pregnancy complications. Regarding inflammatory responses, special receptors of the maternal innate immune system are capable of responding to microbial ligands present in amniotic fluid during intra-amniotic infection, resulting in an exacerbation of inflammatory mediator production, which is associated with the precocious activation of the parturition pathway. Additionally, studies have demonstrated the participation of oxidative stress in the physiopathology of PPROM, highlighting the similarity between PPROM and term pregnancies in relation to degradation and aging of fetal membranes. In this way, PPROM would be a consequence of notable tissue damage resulting from chronic oxidative stress, while PTL would be associated with minimal tissue degradation, resulting from acute exposure associated with a better antioxidant status. This indicates that exacerbation of the maternal inflammatory response and oxidative stress operates in an interdependent way in the pathophysiology of spontaneous preterm birth, including PTL and PPROM.



This work was supported by Unesp (PROPG/PROPE Edital 12/2019).


Conflict of interest

The authors declare that this research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.


  1. 1. Abbas AK, Lichtman AH, Pillai S. Imunologia Celular e Molecular. Vol. 7a. Rio de Janeiro: Elsevier; 2011. pp. 125-130
  2. 2. Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT. PAMPs and DAMPs: Signal 0s that spur autophagy and immunity. Immunological Reviews. 2012;249(1):158-175
  3. 3. Murphy KM, Travers P, Walport M. Janeway Immunologie. Vol. 7. Aufl., Wiesbaden, Deutschland: Spektrum Akademischer Verlag GmbH; 2009. 1119 p
  4. 4. Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Frontiers in Immunology. 2014;5(September):461
  5. 5. Anwar MA, Basith S, Choi S. Negative regulatory approaches to the attenuation of toll-like receptor signaling. Experimental and Molecular Medicine. 2013;45(2):e11
  6. 6. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783-801
  7. 7. De Nardo D. Toll-like receptors: Activation, signalling and transcriptional modulation. Cytokine. 2015;74(2):181-189
  8. 8. Rock KL, Latz E, Ontiveros F, Kono H. The sterile inflammatory response. Annual Review of Immunology. 2010;28:321-342
  9. 9. Chen GY, Nuñez G. Sterile inflammation: Sensing and reacting to damage. Nature Reviews. Immunology. 2010;10(12):826-837
  10. 10. Lee KM, Seong SY. Partial role of TLR4 as a receptor responding to damage-associated molecular pattern. Immunology Letters. 2009;125(1):31-39
  11. 11. Cavassani KA, Ishii M, Wen H, Schaller MA, Lincoln PM, Lukacs NW, et al. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. The Journal of Experimental Medicine. 2008;205(11):2609-2621
  12. 12. Mathews RJ, Sprakes MB, McDermott MF. NOD-like receptors and inflammation. Arthritis Research and Therapy. 2008;10:228
  13. 13. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. The Journal of Biological Chemistry. 2003;278(11):8869-8872
  14. 14. Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L, et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nature Immunology. 2003;4(7):702-707
  15. 15. Uehara A, Fujimoto Y, Kawasaki A, Kusumoto S, Fukase K, Takada H. Meso-diaminopimelic acid and meso-lanthionine, amino acids specific to bacterial peptidoglycans, activate human epithelial cells through NOD1. Journal of Immunology. 2006;177(3):1796-1804
  16. 16. Paiva-Oliveira EL, Silva AC, de Melo HA, Lagrota-Candido J, Quirico-Santos T. Inflamassoma e sua repercussão clínica: revisão da literatura. Rev Ciências Médicas e Biológicas. 2012;11(1):96-102
  17. 17. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. The Journal of Biological Chemistry. 2002;277(24):21119-21122
  18. 18. Hazuda DJ, Lee JC, Young PR. The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1α and interleukin 1β. The Journal of Biological Chemistry. 1988;263(17):8473-8479
  19. 19. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature. 1997;386:619-623
  20. 20. Tsuchiya K, Hara H. The inflammasome and its regulation. Critical Reviews in Immunology. 2014;34(1):41-80
  21. 21. Chen I-Y, Ichinohe T. Response of host inflammasomes to viral infection. Trends in Microbiology. 2015;23(1):55-63
  22. 22. Saxena M, Yeretssian G. NOD-like receptors: Master regulators of inflammation and cancer. Frontiers in Immunology. 2014;5:1-16
  23. 23. Tschopp J, Schroder K. NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nature Reviews Immunology. 2010;10(3):210-215
  24. 24. Clark GF, Schust DJ. Manifestations of immune tolerance in the human female reproductive tract. Frontiers in Immunology. 2013;4:e1-e14
  25. 25. Chaouat G. The Th1/Th2 paradigm: Still important in pregnancy? Seminars in Immunopathology. 2007;29:95-113
  26. 26. Wilczyński JR. Th1/Th2 cytokines balance—Yin and yang of reproductive immunology. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2005;122(2):136-143
  27. 27. Mor G. Inflammation and pregnancy. Annals of the New York Academy of Sciences. 2008;1127(1):121-128
  28. 28. Raghupathy R. Maternal anti-placental cell-mediated reactivity and spontaneous abortions. American Journal of Reproductive Immunology. 1997;37(6):478-484
  29. 29. Makhseed M, Raghupathy R, El-Shazly S, Azizieh F, Al-Harmi JA, Al-Azemi MMK. Pro-inflammatory maternal cytokine profile in preterm delivery. American Journal of Reproductive Immunology. 2003;49(5):308-318
  30. 30. El-Shazly S, Makhseed M, Azizieh F, Raghupathy R. Increased expression of pro-inflammatory cytokines in placentas of women undergoing spontaneous preterm delivery or premature rupture of membranes. American Journal of Reproductive Immunology. 2004;52(1):45-52
  31. 31. Arntzen KJ, Lien E, Austgulen R. Maternal serum levels of interleukin-6 and clinical characteristics of normal delivery at term. Acta Obstetricia et Gynecologica Scandinavica. 1997;76(1):55-60
  32. 32. Kumazaki K, Nakayama M, Yanagihara I, Suehara N, Wada Y. Immunohistochemical distribution of toll-like receptor 4 in term and preterm human placentas from normal and complicated pregnancy including chorioamnionitis. Human Pathology. 2004;35(1):47-54
  33. 33. Patni S, Flynn P, Wynen LP, Seager a L, Morgan G, White JO, et al. An introduction to toll-like receptors and their possible role in the initiation of labour. BJOG. 2007;114(11):1326-1334
  34. 34. Osman I, Young A, Ledingham MA, Thomson AJ, Jordan F, Greer IA, et al. Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Molecular Human Reproduction. 2003;9:41-45
  35. 35. Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel LA, Nien JK. Inflammation in preterm and term labour and delivery. Seminars in Fetal and Neonatal Medicine. 2006;11(5):317-326
  36. 36. Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. The Annals of the New York Academy of Science. 2011;1221:80-87
  37. 37. King AE, Kelly RW, Sallenave J-M, Bocking a D, Challis JRG. Innate immune defences in the human uterus during pregnancy. Placenta. 2007;28(11-12):1099-1106
  38. 38. Hung T-H, Lo L-M, Chiu T-H, Li M-J, Yeh Y-L, Chen S-F, et al. A longitudinal study of oxidative stress and antioxidant status in women with uncomplicated pregnancies throughout gestation. Reproductive Sciences. 2010;17(4):401-409
  39. 39. Little RE, Gladen BC. Levels of lipid peroxides in uncomplicated pregnancy: A review of the literature. Reproductive Toxicology. 1999;13:347-352
  40. 40. Salas-Pacheco JM, Lourenco-Jaramillo DL, Mendez-Hernandez EM, Sandoval-Carrillo AA, Hernandez Rayon YI, Llave-Leon O, et al. Oxidative stress equilibrium during obstetric event in normal pregnancy. The Journal of Maternal-Fetal and Neonatal Medicine. 2016;7058:1-5
  41. 41. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. American Journal of Physiology. Cell Physiology. 2002;282:C227-C241
  42. 42. Moura E, Daher S, Souza E, Mattar R. Aspectos imunogenéticos do parto pré-termo espontâneo. Femina. 2009;1:499-503
  43. 43. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75-84
  44. 44. Birth P, Survival L. Preterm Birth, Long-term Survival, and Fertility. 2016;300(2)
  45. 45. Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. The Bulletin of the World Health Organization. 2010;88(1):31-38
  46. 46. Goldenberg RL, Gravett MG, Iams J, Papageorghiou AT, Waller SA, Kramer M, et al. The preterm birth syndrome: Issues to consider in creating a classification system. American Journal of Obstetrics and Gynecology. 2012;206:113-118
  47. 47. Menon R. Spontaneous preterm birth, a clinical dilemma: Etiologic, pathophysiologic and genetic heterogeneities and racial disparity. Acta Obstetricia et Gynecologica Scandinavica. 2008;87(6):590-600
  48. 48. Sayres WG. Preterm labor. American Family Physician. 2010;81(4):477-484
  49. 49. Murphy DJ. Epidemiology and environmental factors in preterm labour. Best Practice and Research. Clinical Obstetrics and Gynaecology. 2007;21(5):773-789
  50. 50. Anum EA, Springel EH, Shriver MD, Strauss JF. Genetic contributions to disparities in preterm birth. Pediatric Research. 2009;65:1-9
  51. 51. Holst D, Garnier Y. Preterm birth and inflammation—The role of genetic polymorphisms. The European Journal of Obstetrics and Gynecology and Reproductive Biology. 2008;141(1):3-9
  52. 52. Ribeiro de Andrade Ramos B, da Silva MG. The burden of genetic and epigenetic traits in prematurity. Reproductive Sciences. 2017;25(4):471-479
  53. 53. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. The New England Journal of Medicine. 2000;342(20):1500-1507
  54. 54. Kim MJ, Romero R, Gervasi MT, Kim J-S, Yoo W, Lee D-C, et al. Widespread microbial invasion of the chorioamniotic membranes is a consequence and not a cause of intra-amniotic infection. Laboratory Investigation. 2009;89(8):924-936
  55. 55. Gibbs RS, Duff P. Progress in pathogenesis and management of clinical intraamniotic infection. American Journal of Obstetrics and Gynecology. 1991;164(5 PART 1):1317-1326
  56. 56. Edwards RK. Chorioamnionitis and labor. Obstetrics and Gynecology Clinics of North America. 2005;32(2):287-296
  57. 57. Conti N, Torricelli M, Voltolini C, Vannuccini S, Clifton VL, Bloise E, et al. Term histologic chorioamnionitis: A heterogeneous condition. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2015;188:34-38
  58. 58. Newton ER. Preterm labor, preterm premature rupture of membranes, and chorioamnionitis. Clinics in Perinatology. 2005;32(3):571-600
  59. 59. Sperling RS, Newton E, Gibbs RS. Intraamniotic infection in low-birth-weight infants. The Journal of Infectious Diseases. 1988;157(1):113-117
  60. 60. Romero R, Miranda J, Chaiworapongsa T, Korzeniewski SJ, Chaemsaithong P, Gotsch F, et al. Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes. American Journal of Reproductive Immunology. 2014;72(5):458-474
  61. 61. Gibbs RS, Blanco JD, St Clair PJ, Castaneda YS. Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. The Journal of Infectious Diseases. 1982;145(1):1-8
  62. 62. Abrahams VM. The role of the nod-like receptor family in trophoblast innate immune responses. Journal of Reproductive Immunology. 2011;88(2):112-117
  63. 63. Challis JRG, Sloboda DM, Alfaidy N, Lye SJ, Gibb W, Patel FA, et al. Prostaglandins and mechanisms of preterm birth. Reproduction. 2002;124:1-17
  64. 64. Menon R, Fortunato SJ. Infection and the role of inflammation in preterm premature rupture of the membranes. Best Practice and Research. Clinical Obstetrics and Gynaecology. 2007;21(3):467-478
  65. 65. DiGiulio DB. Diversity of microbes in amniotic fluid. Seminars in Fetal and Neonatal Medicine. 2012;17(1):2-11
  66. 66. Zaga-Clavellina V, Garcia-Lopez G, Flores-Herrera H, Espejel-Nuñez A, Flores-Pliego A, Soriano-Becerril D, et al. In vitro secretion profiles of interleukin (IL)-1beta, IL-6, IL-8, IL-10, and TNF alpha after selective infection with Escherichia coli in human fetal membranes. Reproductive Biology and Endocrinology. 2007;5:46
  67. 67. Menon R, Peltier MR, Eckardt J, Fortunato SJ. Diversity in cytokine response to bacteria associated with preterm birth by fetal membranes. American Journal of Obstetrics and Gynecology. 2009;201(3):306.e1-306.e6
  68. 68. Park CW, Yoon BH, Park JS, Jun JK. A fetal and an intra-amniotic inflammatory response is more severe in Preterm labor than in Preterm PROM in the context of funisitis: Unexpected observation in human gestations. PLoS One. 2013;8(5)
  69. 69. Menon R, Yu J, Basanta-Henry P, Brou L, Berga SL, Fortunato SJ, et al. Short fetal leukocyte telomere length and preterm prelabor rupture of the membranes. PLoS One. 2012;7(2):e31136
  70. 70. Chai M, Barker G, Menon R, Lappas M. Increased oxidative stress in human fetal membranes overlying the cervix from term non-labouring and post labour deliveries. Placenta. 2012;33(8):604-610
  71. 71. Menon R, Fortunato SJ. The role of matrix degrading enzymes and apoptosis in rupture of membranes. Journal of the Society for Gynecologic Investigation. 2004;11(7):427-437
  72. 72. Menon R, Boldogh I, Hawkins HK, Woodson M, Polettini J, Syed TA, et al. Histological evidence of oxidative stress and premature senescence in preterm premature rupture of the human fetal membranes recapitulated in vitro. The American Journal of Pathology. 2014;184(6):1740-1751
  73. 73. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. Journal of the American Medical Association. 2004;292(19):2357-2365
  74. 74. Hsieh T-T, Chen S-F, Lo L-M, Li M-J, Yeh Y-L, Hung T-H. The association between maternal oxidative stress at mid-gestation and subsequent pregnancy complications. Reproductive Sciences. 2012;19(5):505-512
  75. 75. Dutta EH, Behnia F, Boldogh I, Saade GR, Taylor BD, Kacerovský M, et al. Oxidative stress damage-associated molecular signaling pathways differentiate spontaneous preterm birth and preterm premature rupture of the membranes. Molecular Human Reproduction. 2015;22(2):143-157
  76. 76. Menon R. Oxidative stress damage as a detrimental factor in preterm birth pathology. Frontiers in Immunology. 2014;5:e1-e14
  77. 77. de Andrade Ramos BR, Witkin SS. The influence of oxidative stress and autophagy cross regulation on pregnancy outcome. Cell Stress and Chaperones. 2016;21(5):755-762
  78. 78. Menon R, Bonney EA, Condon J, Mesiano S, Taylor RN. Novel concepts on pregnancy clocks and alarms: Redundancy and synergy in human parturition. Human Reproduction Update. 2016;22(5):535-560
  79. 79. Menon R, Behnia F, Polettini J, Saade GR, Campisi J, Velarde M. Placental membrane aging and HMGB1 signaling associated with human parturition. Aging (Albany NY). 2016;8(2):216-230
  80. 80. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: Update on toll-like receptors. Nature Immunology. 2010;11(5):373-384
  81. 81. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, et al. Cutting edge: Role of toll-like receptor 1 in mediating immune response to microbial lipoproteins. Journal of Immunology. 2002;169(1):10-14
  82. 82. Akira S. Mammalian toll-like receptors. Current Opinion in Immunology. 2003;15(1):5-11
  83. 83. Kim YM, Romero R, Chaiworapongsa T, Kim GJ, Kim MR, Kuivaniemi H, et al. Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. American Journal of Obstetrics and Gynecology. 2004;191(4):1346-1355
  84. 84. Moço NP, Martin LF, Pereira AC, Polettini J, Peraçoli JC, Coelho KIR, et al. Gene expression and protein localization of TLR-1, −2, −4 and −6 in amniochorion membranes of pregnancies complicated by histologic chorioamnionitis. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2013;171(1):12-17
  85. 85. Rindsjö E, Holmlund U, Sverremark-Ekström E, Papadogiannakis N, Scheynius A. Toll-like receptor-2 expression in normal and pathologic human placenta. Human Pathology. 2007;38(3):468-473
  86. 86. Kacerovsky M, Andrys C, Hornychova H, Pliskova L, Lancz K, Musilova I, et al. Amniotic fluid soluble toll-like receptor 4 in pregnancies complicated by preterm prelabor rupture of the membranes. The Journal of Maternal-Fetal and Neonatal Medicine. 2012;25(7):1148-1155
  87. 87. Kacerovsky M, Andrys C, Drahosova M, Musilova I, Hornychova H, Lesko D, et al. Soluble toll-like receptor 1 family members in the amniotic fluid of women with preterm prelabor rupture of the membranes. The Journal of Maternal-Fetal and Neonatal Medicine. 2012;25(9):1699-1704
  88. 88. Keelan JA, Marvin KW, Sato TA, Coleman M, McCowan LM, Mitchell MD. Cytokine abundance in placental tissues: Evidence of inflammatory activation in gestational membranes with term and preterm parturition. American Journal of Obstetrics and Gynecology. 1999;181(6):1530-1536
  89. 89. Holmlund U, Cebers G, Dahlfors AR, Sandstedt B, Bremme K, Ekström ES, et al. Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta. Immunology. 2002;107(1):145-151
  90. 90. Gonzalez JM, Xu H, Ofori E, Elovitz MA. Toll-like receptors in the uterus, cervix, and placenta: Is pregnancy an immunosuppressed state? American Journal of Obstetrics and Gynecology. 2007;197(3):e1-e6
  91. 91. Beijar ECE, Mallard C, Powell TL. Expression and subcellular localization of TLR-4 in term and first trimester human placenta. Placenta. 2006;27(2-3):322-326
  92. 92. Bertin J, Nir WJ, Fischer CM, Tayber OV, Errada PR, Grant JR, et al. Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-??B. The Journal of Biological Chemistry. 1999;274(19):12955-12958
  93. 93. Inohara N, Koseki T, Peso L, Hu Y, Yee C, Chen S, et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. 1999;274(21):14560-14567
  94. 94. Costello MJ, Joyce SK, Abrahams VM. NOD protein expression and function in first trimester trophoblast cells. American Journal of Reproductive Immunology. 2007;57(1):67-80
  95. 95. Romero R, Xu Y, Plazyo O, Chaemsaithong P, Chaiworapongsa T, Unkel R, et al. A role for the Inflammasome in spontaneous labor at term. American Journal of Reproductive Immunology. 2016;79(6):e12440
  96. 96. Wang Z, Liu M, Nie X, Zhang Y, Chen Y, Zhu L, et al. NOD1 and NOD2 control the invasiveness of trophoblast cells via the MAPK/p38 signaling pathway in human first-trimester pregnancy. Placenta. 2015;36(6):652-660
  97. 97. Pontillo A, Girardelli M, Agostinis C, Masat E, Bulla R, Crovella S. Bacterial LPS differently modulates inflammasome gene expression and IL-1β secretion in trophoblast cells, decidual stromal cells, and decidual endothelial cells. Reproductive Sciences. 2013;20(5):563-566

Written By

Natália Prearo Moço, Bruna Ribeiro de Andrade Ramos, Mariana de Castro Silva, Jossimara Polettini, Ramkumar Menon and Márcia Guimarães da Silva

Submitted: January 10th, 2019 Reviewed: July 3rd, 2019 Published: November 25th, 2019